Nigerian (NSE) Pharma Industry Analysis
UpdatedJan 27, 2023
DataAggregated Company Financials
Companies6
- 7D2.4%
- 3M9.9%
- 1Y20.5%
- YTD2.6%
In the last week, the Pharma industry is up 2.4%, with Fidson Healthcare up 4.3%. This means that the industry has gained 21% over the past year.
Industry Valuation and Performance
Has the Nigerian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 27 Jan 2023 | ₦42.0b | ₦83.8b | ₦7.3b | 4.7x | 5.7x | 0.5x |
| Sun, 25 Dec 2022 | ₦39.2b | ₦83.8b | ₦7.3b | 4.4x | 5.3x | 0.5x |
| Tue, 22 Nov 2022 | ₦36.0b | ₦83.8b | ₦7.3b | 4.1x | 4.9x | 0.4x |
| Thu, 20 Oct 2022 | ₦37.7b | ₦81.7b | ₦7.2b | 7.1x | 5.2x | 0.5x |
| Sat, 17 Sep 2022 | ₦40.5b | ₦81.7b | ₦7.2b | 7.1x | 5.6x | 0.5x |
| Mon, 15 Aug 2022 | ₦40.6b | ₦81.7b | ₦7.2b | 7.2x | 5.6x | 0.5x |
| Wed, 13 Jul 2022 | ₦43.3b | ₦76.4b | ₦6.4b | 6.8x | 6.7x | 0.6x |
| Fri, 10 Jun 2022 | ₦42.1b | ₦76.3b | ₦5.8b | 7.4x | 7.3x | 0.6x |
| Sun, 08 May 2022 | ₦40.0b | ₦76.3b | ₦5.8b | 7.2x | 6.9x | 0.5x |
| Tue, 05 Apr 2022 | ₦34.8b | ₦67.9b | ₦4.7b | 10.5x | 7.4x | 0.5x |
| Thu, 03 Mar 2022 | ₦38.0b | ₦67.9b | ₦4.7b | 12.2x | 8.1x | 0.6x |
| Sat, 29 Jan 2022 | ₦34.8b | ₦61.7b | ₦4.9b | 7.3x | 7.1x | 0.6x |
| Mon, 27 Dec 2021 | ₦32.2b | ₦61.5b | ₦4.7b | 7.2x | 6.8x | 0.5x |
| Wed, 24 Nov 2021 | ₦32.3b | ₦61.5b | ₦4.7b | 7.5x | 6.9x | 0.5x |
| Fri, 22 Oct 2021 | ₦33.0b | ₦55.8b | ₦3.6b | 8.9x | 9.1x | 0.6x |
| Sun, 19 Sep 2021 | ₦32.2b | ₦55.8b | ₦3.6b | 8.2x | 8.9x | 0.6x |
| Tue, 17 Aug 2021 | ₦32.4b | ₦62.2b | ₦2.8b | 7.8x | 11.7x | 0.5x |
| Tue, 01 Jun 2021 | ₦29.3b | ₦61.7b | ₦3.0b | 6.7x | 9.8x | 0.5x |
| Fri, 05 Mar 2021 | ₦29.8b | ₦57.9b | ₦2.1b | 7.8x | 14x | 0.5x |
| Mon, 07 Dec 2020 | ₦29.6b | ₦56.3b | ₦2.3b | 9.3x | 13.2x | 0.5x |
| Thu, 10 Sep 2020 | ₦23.5b | ₦53.5b | ₦1.9b | 7.2x | 12.1x | 0.4x |
| Wed, 03 Jun 2020 | ₦25.7b | ₦52.0b | ₦1.4b | 9.4x | 18.2x | 0.5x |
| Sat, 07 Mar 2020 | ₦15.5b | ₦52.0b | ₦1.6b | 4.7x | 9.4x | 0.3x |
Price to Earnings Ratio
10.7x
Current Industry PE
- Investors are pessimistic on the Nigerien Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 5.7x which is lower than its 3-year average PE of 9.6x.
- The industry is trading close to its 3-year average PS ratio of 0.48x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 65% per year over the last three years.
- Revenues for these companies have grown 17% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Nigerian Pharma compare with similar industries?
| NG Market | 0.33% | |
| Healthcare | 2.23% | |
| Pharma | 2.38% | |
| Pharma | 2.38% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| FIDSON Fidson Healthcare | ₦9.75 | 4.3% +₦918.0m | 42.1% | PE4.6x | |
| GLAXOSMITH GlaxoSmithKline Consumer Nigeria | ₦6.80 | 2.3% +₦179.4m | 11.5% | PE8x |